Plasma brain natriuretic peptide as a biomarker for haemodynamic outcome and mortality following pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

Interactive Cardiovascular and Thoracic Surgery

Volumn 15, Issue 6, 2012, Pages 973-978

  Surie, Sulaiman ^a   Reesink, Herre J ^a   Van Der Plas, Mart N ^b   Hardziyenka, Maxim ^a   Kloek, Jaap J ^a   Zwinderman, Aeilko H ^a   Bresser, Paul ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

Author keywords

Biomarker; Brain natriuretic peptide; Chronic thromboembolic pulmonary hypertension; Pulmonary endarterectomy; Right ventricular dysfunction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CONTROLLED STUDY; ENDARTERECTOMY; EXERCISE TEST; FEMALE; FUNCTIONAL STATUS; HEART INDEX; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE; LENGTH OF STAY; LUNG PRESSURE; LUNG RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PULMONARY ENDARTERECTOMY; RECEIVER OPERATING CHARACTERISTIC; SURGICAL MORTALITY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; ENDARTERECTOMY; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; INTENSIVE CARE UNITS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PULMONARY EMBOLISM; RESPIRATION, ARTIFICIAL; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT; YOUNG ADULT;

EID: 84870194036     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs415     Document Type: Article

References (25)

1. Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465-72.
2. Riedel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982;81:151-8. (Pubitemid 12165545)
3. Reesink HJ, Marcus JT, Tulevski II, Jamieson S, Kloek JJ, Vonk NA et al. Reverse right ventricular remodeling after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: utility of magnetic resonance imaging to demonstrate restoration of the right ventricle. J Thorac Cardiovasc Surg 2007;133:58-64. (Pubitemid 46014247)
4. Archibald CJ, Auger WR, Fedullo PF, Channick RN, Kerr KM, Jamieson SW et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 1999;160:523-8. (Pubitemid 29380667)
5. Kramm T, Mayer E, Dahm M, Guth S, Menzel T, Pitton M et al. Long-term results after thromboendarterectomy for chronic pulmonary embolism. Eur J Cardiothorac Surg 1999;15:579-83.
6. Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2008;177: 1122-7. (Pubitemid 351717571)
7. Dartevelle P, Fadel E, Mussot S, Chapelier A, Herve P, de PM et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23: 637-48. (Pubitemid 38456010)
8. Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003;76:1457-62.
9. Bresser P, Fedullo PF, Auger WR, Channick RN, Robbins IM, Kerr KM et al. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:595-600. (Pubitemid 38456003)
10. Bresser P, Pepke-Zaba J, Jais X, Humbert M, Hoeper MM. Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm. Proc Am Thorac Soc 2006;3:594-600. (Pubitemid 44411626)
11. Reesink HJ, Surie S, Kloek JJ, Tan HL, Tepaske R, Fedullo PF et al. Bosentan as a bridge to pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 2010;139: 85-91.
12. Kreitner KF, Kunz RP, Ley S, Oberholzer K, Neeb D, Gast KK et al. Chronic thromboembolic pulmonary hypertension - assessment by magnetic resonance imaging. Eur Radiol 2007;17:11-21. (Pubitemid 46063024)
13. Boomsma F, van den Meiracker AH. Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use. Cardiovasc Res 2001; 51:442-9. (Pubitemid 32718592)
14. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003;362:316-22. (Pubitemid 36936846)
15. Nagaya N, Nishikimi T, Okano Y, Uematsu M, Satoh T, Kyotani S et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998;31:202-8. (Pubitemid 28064743)
16. Nagaya N, Nishikimi T, Uematsu M, Satoh T, Kyotani S, Sakamaki F et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000;102:865-70.
17. Nagaya N, Ando M, Oya H, Ohkita Y, Kyotani S, Sakamaki F et al. Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterectomy. Ann Thorac Surg 2002; 74:180-4. (Pubitemid 34742002)
18. Reesink HJ, Tulevski II, Marcus JT, Boomsma F, Kloek JJ, Vonk NA et al. Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension. Ann Thorac Surg 2007;84:537-43. (Pubitemid 47069203)
19. Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology 1992;182:393-8.
20. Surie S, Bouma BJ, Bruin-Bon RA, Hardziyenka M, Kloek JJ, van der Plas MN et al. Time course of restoration of systolic and diastolic right ventricular function after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Am Heart J 2011;161: 1046-52.
21. Reesink HJ, van der Plas MN, Verhey NE, van Steenwijk RP, Kloek JJ, Bresser P. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 2007;133:510-6. (Pubitemid 46136286)
22. ATS Committee on Proficieny Standards for Clinical Pulmonary Function Laboratories statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
23. Tulevski II, Hirsch A, Sanson BJ, Romkes H, van der Wall EE, van Veldhuisen DJ et al. Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism. Thromb Haemost 2001;86:1193-6. (Pubitemid 33064567)
24. Jensen KW, Kerr KM, Fedullo PF, Kim NH, Test VJ, Ben-Yehuda O et al. Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation 2009;120:1248-54.
25. Bresser P, Surie S. Medical therapy for chronic thromboembolic pulmonary hypertension. Multidiscip Resp Med 2008;3:434-9.